Research Analysts’ price target changes for Thursday, November 14th:
Acrivon Therapeutics (NASDAQ:ACRV) had its price target cut by BMO Capital Markets from $28.00 to $27.00. The firm currently has an outperform rating on the stock.
Agree Realty (NYSE:ADC) had its target price raised by Mizuho from $75.00 to $80.00. The firm currently has a neutral rating on the stock.
Adient (NYSE:ADNT) had its price target trimmed by Morgan Stanley from $21.00 to $19.00. Morgan Stanley currently has an underweight rating on the stock.
Applied Industrial Technologies (NYSE:AIT) had its target price increased by Oppenheimer Holdings Inc. from $260.00 to $305.00. Oppenheimer Holdings Inc. currently has an outperform rating on the stock.
Allogene Therapeutics (NASDAQ:ALLO) had its price target trimmed by Piper Sandler from $11.00 to $9.00. They currently have an overweight rating on the stock.
Alumis (NASDAQ:ALMS) had its target price cut by HC Wainwright from $30.00 to $26.00. The firm currently has a buy rating on the stock.
Amazon.com (NASDAQ:AMZN) had its price target boosted by Needham & Company LLC from $210.00 to $250.00. The firm currently has a buy rating on the stock.
Abercrombie & Fitch (NYSE:ANF) had its price target raised by UBS Group AG from $165.00 to $170.00. UBS Group AG currently has a neutral rating on the stock.
Air Products and Chemicals (NYSE:APD) had its target price raised by BMO Capital Markets from $323.00 to $350.00. The firm currently has an outperform rating on the stock.
American Public Education (NASDAQ:APEI) had its price target boosted by Truist Financial Co. from $15.00 to $20.00. Truist Financial Co. currently has a hold rating on the stock.
Aptiv (NYSE:APTV) had its price target lowered by Morgan Stanley from $68.00 to $60.00. Morgan Stanley currently has an underweight rating on the stock.
Archrock (NYSE:AROC) had its price target raised by Royal Bank of Canada from $26.00 to $27.00. Royal Bank of Canada currently has an outperform rating on the stock.
Avino Silver & Gold Mines (NYSE:ASM) had its target price boosted by HC Wainwright from $1.50 to $1.80. HC Wainwright currently has a buy rating on the stock.
Avino Silver & Gold Mines (NYSE:ASM) had its target price boosted by HC Wainwright from $1.50 to $1.80. They currently have a buy rating on the stock.
Astria Therapeutics (NASDAQ:ATXS) had its target price boosted by Oppenheimer Holdings Inc. from $26.00 to $28.00. Oppenheimer Holdings Inc. currently has an outperform rating on the stock.
AvalonBay Communities (NYSE:AVB) had its price target reduced by Scotiabank from $244.00 to $241.00. The firm currently has a sector perform rating on the stock.
Ayr Wellness (OTCMKTS:AYRWF) had its price target cut by Roth Mkm from $3.50 to $3.00. The firm currently has a buy rating on the stock.
Dutch Bros (NYSE:BROS) had its target price raised by Stifel Nicolaus from $42.00 to $53.00. The firm currently has a buy rating on the stock.
Burlington Stores (NYSE:BURL) had its target price boosted by UBS Group AG from $270.00 to $280.00. The firm currently has a neutral rating on the stock.
BrightView (NYSE:BV) had its price target increased by Robert W. Baird from $18.00 to $20.00. The firm currently has an outperform rating on the stock.
BWX Technologies (NYSE:BWXT) had its price target raised by Bank of America Co. from $115.00 to $160.00. Bank of America Co. currently has a buy rating on the stock.
Capricor Therapeutics (NASDAQ:CAPR) had its price target boosted by Cantor Fitzgerald from $25.00 to $30.00. They currently have an overweight rating on the stock.
CAVA Group (NYSE:CAVA) had its price target increased by Morgan Stanley from $123.00 to $135.00. Morgan Stanley currently has an equal weight rating on the stock.
Chegg (NYSE:CHGG) had its price target reduced by Piper Sandler from $2.00 to $1.50. The firm currently has an underweight rating on the stock.
Chegg (NYSE:CHGG) had its target price cut by The Goldman Sachs Group, Inc. from $3.75 to $1.75. The firm currently has a neutral rating on the stock.
Clene (NASDAQ:CLNN) had its target price cut by Canaccord Genuity Group Inc. from $86.00 to $83.00. They currently have a buy rating on the stock.
Cannae (NYSE:CNNE) had its target price increased by Royal Bank of Canada from $26.00 to $27.00. Royal Bank of Canada currently has an outperform rating on the stock.
Camden Property Trust (NYSE:CPT) had its price target reduced by Scotiabank from $132.00 to $130.00. They currently have a sector perform rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its target price raised by Bank of America Co. from $60.00 to $72.00. The firm currently has a buy rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its price target boosted by Barclays PLC from $49.00 to $56.00. They currently have an equal weight rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its target price raised by UBS Group AG from $55.00 to $62.00. The firm currently has a neutral rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its price target boosted by Wells Fargo & Company from $57.00 to $60.00. The firm currently has an equal weight rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its price target boosted by Morgan Stanley from $58.00 to $62.00. Morgan Stanley currently has an overweight rating on the stock.
Cisco Systems (NASDAQ:CSCO) had its price target boosted by Piper Sandler from $52.00 to $57.00. Piper Sandler currently has a neutral rating on the stock.
Coterra Energy (NYSE:CTRA) had its price target raised by Susquehanna from $30.00 to $33.00. Susquehanna currently has a positive rating on the stock.
Coterra Energy (NYSE:CTRA) had its price target increased by Piper Sandler from $32.00 to $35.00. Piper Sandler currently has an overweight rating on the stock.
Coterra Energy (NYSE:CTRA) had its target price boosted by Barclays PLC from $31.00 to $33.00. They currently have an overweight rating on the stock.
Coterra Energy (NYSE:CTRA) had its target price raised by Morgan Stanley from $27.00 to $29.00. Morgan Stanley currently has an equal weight rating on the stock.
Coterra Energy (NYSE:CTRA) had its price target raised by Truist Financial Co. from $31.00 to $33.00. Truist Financial Co. currently has a buy rating on the stock.
Cybin (NYSE:CYBN) had its target price trimmed by Canaccord Genuity Group Inc. from $96.00 to $86.00. Canaccord Genuity Group Inc. currently has a buy rating on the stock.
CyberArk Software (NASDAQ:CYBR) had its price target raised by Canaccord Genuity Group Inc. from $310.00 to $330.00. They currently have a buy rating on the stock.
CyberArk Software (NASDAQ:CYBR) had its price target boosted by Royal Bank of Canada from $328.00 to $358.00. Royal Bank of Canada currently has an outperform rating on the stock.
CyberArk Software (NASDAQ:CYBR) had its price target raised by Barclays PLC from $330.00 to $335.00. They currently have an overweight rating on the stock.
CyberArk Software (NASDAQ:CYBR) had its price target raised by Stifel Nicolaus from $306.00 to $335.00. They currently have a buy rating on the stock.
CyberArk Software (NASDAQ:CYBR) had its price target boosted by Wells Fargo & Company from $300.00 to $350.00. Wells Fargo & Company currently has an overweight rating on the stock.
CyberArk Software (NASDAQ:CYBR) had its target price raised by UBS Group AG from $340.00 to $360.00. The firm currently has a buy rating on the stock.
CyberArk Software (NASDAQ:CYBR) had its price target boosted by Susquehanna from $320.00 to $345.00. Susquehanna currently has a positive rating on the stock.
CyberArk Software (NASDAQ:CYBR) had its price target raised by Piper Sandler from $300.00 to $345.00. They currently have an overweight rating on the stock.
CyberArk Software (NASDAQ:CYBR) had its price target increased by JMP Securities from $310.00 to $360.00. They currently have a market outperform rating on the stock.
CyberArk Software (NASDAQ:CYBR) had its price target raised by KeyCorp from $340.00 to $355.00. KeyCorp currently has an overweight rating on the stock.
Digi International (NASDAQ:DGII) had its target price raised by Piper Sandler from $26.00 to $32.00. The firm currently has a neutral rating on the stock.
Doximity (NASDAQ:DOCS) had its price target increased by Truist Financial Co. from $35.00 to $49.00. The firm currently has a hold rating on the stock.
Amdocs (NASDAQ:DOX) had its target price cut by Barclays PLC from $113.00 to $111.00. They currently have an overweight rating on the stock.
Driven Brands (NASDAQ:DRVN) had its price target increased by Stifel Nicolaus from $20.00 to $22.00. Stifel Nicolaus currently has a buy rating on the stock.
Duolingo (NASDAQ:DUOL) had its target price raised by UBS Group AG from $355.00 to $408.00. They currently have a buy rating on the stock.
Excelerate Energy (NYSE:EE) had its target price boosted by Morgan Stanley from $23.00 to $25.00. The firm currently has an equal weight rating on the stock.
Everest Group (NYSE:EG) had its price target reduced by BMO Capital Markets from $383.00 to $372.00. They currently have a market perform rating on the stock.
Essential Properties Realty Trust (NYSE:EPRT) had its target price raised by Mizuho from $31.00 to $35.00. The firm currently has an outperform rating on the stock.
Essential Properties Realty Trust (NYSE:EPRT) had its price target increased by UBS Group AG from $39.00 to $40.00. UBS Group AG currently has a buy rating on the stock.
Equity Residential (NYSE:EQR) had its target price lowered by Scotiabank from $81.00 to $78.00. The firm currently has a sector perform rating on the stock.
4D Molecular Therapeutics (NASDAQ:FDMT) had its target price cut by Royal Bank of Canada from $40.00 to $39.00. Royal Bank of Canada currently has an outperform rating on the stock.
Fidelis Insurance (NYSE:FIHL) had its price target increased by Keefe, Bruyette & Woods from $25.00 to $26.00. Keefe, Bruyette & Woods currently has an outperform rating on the stock.
Shift4 Payments (NYSE:FOUR) had its price target increased by DA Davidson from $118.00 to $126.00. They currently have a buy rating on the stock.
Shift4 Payments (NYSE:FOUR) had its target price boosted by The Goldman Sachs Group, Inc. from $106.00 to $119.00. The firm currently has a buy rating on the stock.
Freshpet (NASDAQ:FRPT) had its target price raised by Oppenheimer Holdings Inc. from $155.00 to $180.00. Oppenheimer Holdings Inc. currently has an outperform rating on the stock.
Genius Sports (NYSE:GENI) had its price target increased by The Goldman Sachs Group, Inc. from $8.50 to $11.50. The Goldman Sachs Group, Inc. currently has a buy rating on the stock.
Griffon (NYSE:GFF) had its target price raised by Stephens from $85.00 to $100.00. They currently have an overweight rating on the stock.
Gaming and Leisure Properties (NASDAQ:GLPI) had its price target lowered by Mizuho from $52.00 to $51.00. They currently have a neutral rating on the stock.
Groupon (NASDAQ:GRPN) had its target price lowered by The Goldman Sachs Group, Inc. from $11.00 to $8.00. They currently have a sell rating on the stock.
Health Catalyst (NASDAQ:HCAT) had its target price raised by Stephens from $7.00 to $9.00. Stephens currently has an equal weight rating on the stock.
Hillenbrand (NYSE:HI) had its price target cut by KeyCorp from $45.00 to $40.00. They currently have an overweight rating on the stock.
HIVE Digital Technologies (NASDAQ:HIVE) had its price target increased by Canaccord Genuity Group Inc. from $6.00 to $7.00. They currently have a buy rating on the stock.
Honeywell International (NASDAQ:HON) had its target price boosted by Bank of America Co. from $220.00 to $240.00. Bank of America Co. currently has a neutral rating on the stock.
Hut 8 (NASDAQ:HUT) had its target price increased by Benchmark Co. from $17.00 to $32.00. They currently have a buy rating on the stock.
Hut 8 (NASDAQ:HUT) had its target price raised by Needham & Company LLC from $21.00 to $32.00. They currently have a buy rating on the stock.
Immunome (NASDAQ:IMNM) had its price target lowered by Piper Sandler from $23.00 to $21.00. Piper Sandler currently has an overweight rating on the stock.
Incyte (NASDAQ:INCY) had its target price increased by Royal Bank of Canada from $72.00 to $80.00. Royal Bank of Canada currently has a sector perform rating on the stock.
Innoviz Technologies (NASDAQ:INVZ) had its target price lowered by The Goldman Sachs Group, Inc. from $1.00 to $0.75. The Goldman Sachs Group, Inc. currently has a neutral rating on the stock.
Ionis Pharmaceuticals (NASDAQ:IONS) had its target price trimmed by Piper Sandler from $65.00 to $62.00. The firm currently has an overweight rating on the stock.
Jefferies Financial Group (NYSE:JEF) had its target price raised by Oppenheimer Holdings Inc. from $73.00 to $83.00. The firm currently has an outperform rating on the stock.
KORU Medical Systems (NASDAQ:KRMD) had its price target increased by Piper Sandler from $3.00 to $3.50. The firm currently has an overweight rating on the stock.
KORU Medical Systems (NASDAQ:KRMD) had its target price boosted by Canaccord Genuity Group Inc. from $3.00 to $4.00. They currently have a buy rating on the stock.
Kezar Life Sciences (NASDAQ:KZR) had its target price cut by Wells Fargo & Company from $20.00 to $11.00. They currently have an equal weight rating on the stock.
Luminar Technologies (NASDAQ:LAZR) had its target price cut by The Goldman Sachs Group, Inc. from $0.75 to $0.50. The firm currently has a sell rating on the stock.
loanDepot (NYSE:LDI) had its price target boosted by The Goldman Sachs Group, Inc. from $1.70 to $2.70. They currently have a sell rating on the stock.
Lear (NYSE:LEA) had its price target trimmed by Morgan Stanley from $145.00 to $135.00. They currently have an overweight rating on the stock.
Lincoln Electric (NASDAQ:LECO) had its price target increased by KeyCorp from $210.00 to $230.00. KeyCorp currently has an overweight rating on the stock.
Largo (NYSE:LGO) had its price target lowered by HC Wainwright from $4.40 to $4.20. They currently have a buy rating on the stock.
Life360 (NASDAQ:LIF) had its price target boosted by JMP Securities from $40.00 to $55.00. They currently have a market outperform rating on the stock.
Lineage (NASDAQ:LINE) had its price target reduced by The Goldman Sachs Group, Inc. from $104.00 to $89.00. They currently have a buy rating on the stock.
Lumentum (NASDAQ:LITE) had its price target boosted by Morgan Stanley from $61.00 to $76.00. Morgan Stanley currently has an equal weight rating on the stock.
Linamar (TSE:LNR) had its price target reduced by CIBC from C$85.00 to C$84.00.
Lexeo Therapeutics (NASDAQ:LXEO) had its target price boosted by HC Wainwright from $21.00 to $23.00. HC Wainwright currently has a buy rating on the stock.
Live Nation Entertainment (NYSE:LYV) had its price target increased by Bank of America Co. from $125.00 to $149.00. Bank of America Co. currently has a buy rating on the stock.
Mastercard (NYSE:MA) had its price target boosted by Morgan Stanley from $544.00 to $564.00. They currently have an overweight rating on the stock.
Mastercard (NYSE:MA) had its target price boosted by BMO Capital Markets from $550.00 to $565.00. They currently have an outperform rating on the stock.
Mastercard (NYSE:MA) had its target price boosted by UBS Group AG from $590.00 to $610.00. The firm currently has a buy rating on the stock.
Mid-America Apartment Communities (NYSE:MAA) had its target price trimmed by Scotiabank from $174.00 to $173.00. Scotiabank currently has a sector perform rating on the stock.
MeiraGTx (NASDAQ:MGTX) had its price target boosted by Royal Bank of Canada from $9.00 to $11.00. Royal Bank of Canada currently has an outperform rating on the stock.
Topgolf Callaway Brands (NYSE:MODG) had its target price lowered by The Goldman Sachs Group, Inc. from $14.00 to $12.00. The firm currently has a neutral rating on the stock.
NextNav (NASDAQ:NN) had its target price raised by B. Riley from $12.00 to $20.00. B. Riley currently has a buy rating on the stock.
NNN REIT (NYSE:NNN) had its price target trimmed by UBS Group AG from $49.00 to $43.00. UBS Group AG currently has a neutral rating on the stock.
Natera (NASDAQ:NTRA) had its target price boosted by Morgan Stanley from $132.00 to $176.00. The firm currently has an overweight rating on the stock.
NU (NYSE:NU) had its target price raised by The Goldman Sachs Group, Inc. from $17.00 to $19.00. They currently have a buy rating on the stock.
NU (NYSE:NU) had its price target boosted by KeyCorp from $15.00 to $17.00. The firm currently has an overweight rating on the stock.
NU (NYSE:NU) had its price target raised by Susquehanna from $16.00 to $18.00. The firm currently has a positive rating on the stock.
NVIDIA (NASDAQ:NVDA) had its price target raised by Susquehanna from $160.00 to $180.00. They currently have a positive rating on the stock.
NVIDIA (NASDAQ:NVDA) had its target price increased by HSBC Holdings plc from $145.00 to $200.00. HSBC Holdings plc currently has a buy rating on the stock.
NVIDIA (NASDAQ:NVDA) had its target price raised by Oppenheimer Holdings Inc. from $150.00 to $175.00. Oppenheimer Holdings Inc. currently has an outperform rating on the stock.
NVIDIA (NASDAQ:NVDA) had its price target boosted by Raymond James from $140.00 to $170.00. The firm currently has a strong-buy rating on the stock.
Northwest Natural (NYSE:NWN) had its target price lowered by Stifel Nicolaus from $45.00 to $44.00. They currently have a buy rating on the stock.
Realty Income (NYSE:O) had its price target reduced by UBS Group AG from $72.00 to $71.00. UBS Group AG currently has a buy rating on the stock.
OptimizeRx (NASDAQ:OPRX) had its target price trimmed by Stifel Nicolaus from $13.00 to $8.00. Stifel Nicolaus currently has a buy rating on the stock.
OptimizeRx (NASDAQ:OPRX) had its price target lowered by Barclays PLC from $11.00 to $5.00. They currently have an equal weight rating on the stock.
OptimizeRx (NASDAQ:OPRX) had its price target lowered by JMP Securities from $16.00 to $8.00. They currently have a market outperform rating on the stock.
OptimizeRx (NASDAQ:OPRX) had its target price lowered by Royal Bank of Canada from $14.00 to $7.00. They currently have an outperform rating on the stock.
Occidental Petroleum (NYSE:OXY) had its price target trimmed by Susquehanna from $77.00 to $65.00. The firm currently has a positive rating on the stock.
Palo Alto Networks (NASDAQ:PANW) had its price target boosted by Stifel Nicolaus from $385.00 to $440.00. They currently have a buy rating on the stock.
Progyny (NASDAQ:PGNY) had its target price lowered by Barclays PLC from $30.00 to $17.00. Barclays PLC currently has an overweight rating on the stock.
Plug Power (NASDAQ:PLUG) had its price target reduced by Wells Fargo & Company from $3.00 to $2.00. They currently have an equal weight rating on the stock.
Plug Power (NASDAQ:PLUG) had its price target cut by Piper Sandler from $1.60 to $1.40. The firm currently has an underweight rating on the stock.
Primoris Services (NASDAQ:PRIM) had its target price increased by UBS Group AG from $75.00 to $100.00. The firm currently has a buy rating on the stock.
Paysafe (NYSE:PSFE) had its price target lowered by Susquehanna from $23.00 to $21.00. They currently have a neutral rating on the stock.
PSQ (NYSE:PSQH) had its target price cut by Roth Mkm from $5.00 to $3.50. The firm currently has a buy rating on the stock.
Portman Ridge Finance (NASDAQ:PTMN) had its price target reduced by Keefe, Bruyette & Woods from $19.00 to $18.00. They currently have a market perform rating on the stock.
Restaurant Brands International (NYSE:QSR) (TSE:QSR) had its target price cut by Stifel Nicolaus from $77.00 to $72.00. The firm currently has a hold rating on the stock.
Riley Exploration Permian (NYSE:REPX) had its target price boosted by Truist Financial Co. from $40.00 to $45.00. Truist Financial Co. currently has a buy rating on the stock.
Rigel Pharmaceuticals (NASDAQ:RIGL) had its target price increased by Piper Sandler from $15.00 to $23.00. Piper Sandler currently has a neutral rating on the stock.
Rivian Automotive (NASDAQ:RIVN) had its price target increased by The Goldman Sachs Group, Inc. from $10.00 to $12.00. The firm currently has a neutral rating on the stock.
Rocket Lab USA (NASDAQ:RKLB) had its target price increased by Cantor Fitzgerald from $7.00 to $24.00. Cantor Fitzgerald currently has an overweight rating on the stock.
Rocket Lab USA (NASDAQ:RKLB) had its target price raised by Bank of America Co. from $10.00 to $30.00. Bank of America Co. currently has a buy rating on the stock.
Rocket Companies (NYSE:RKT) had its target price raised by Bank of America Co. from $14.00 to $15.00. Bank of America Co. currently has an underperform rating on the stock.
Rocket Companies (NYSE:RKT) had its target price trimmed by UBS Group AG from $14.00 to $12.50. They currently have a sell rating on the stock.
Rocket Companies (NYSE:RKT) had its price target lowered by Keefe, Bruyette & Woods from $20.00 to $16.00. The firm currently has a market perform rating on the stock.
Rocket Companies (NYSE:RKT) had its price target cut by Piper Sandler from $17.00 to $16.00. They currently have a neutral rating on the stock.
Ross Stores (NASDAQ:ROST) had its target price cut by Wells Fargo & Company from $175.00 to $165.00. Wells Fargo & Company currently has an overweight rating on the stock.
Riskified (NYSE:RSKD) had its target price trimmed by UBS Group AG from $4.75 to $4.50. They currently have a neutral rating on the stock.
Riskified (NYSE:RSKD) had its target price cut by Keefe, Bruyette & Woods from $5.50 to $5.25. Keefe, Bruyette & Woods currently has a market perform rating on the stock.
SEA (NYSE:SE) had its price target boosted by Barclays PLC from $94.00 to $131.00. Barclays PLC currently has an overweight rating on the stock.
Sangamo Therapeutics (NASDAQ:SGMO) had its price target boosted by Barclays PLC from $3.00 to $9.00. They currently have an overweight rating on the stock.
Similarweb (NYSE:SMWB) had its target price raised by Needham & Company LLC from $11.00 to $14.00. The firm currently has a buy rating on the stock.
SoundHound AI (NASDAQ:SOUN) had its target price raised by HC Wainwright from $7.00 to $8.00. They currently have a buy rating on the stock.
Spire Global (NYSE:SPIR) had its price target raised by Robert W. Baird from $9.00 to $16.00. They currently have a neutral rating on the stock.
Spotify Technology (NYSE:SPOT) had its price target raised by Canaccord Genuity Group Inc. from $475.00 to $525.00. They currently have a buy rating on the stock.
Spotify Technology (NYSE:SPOT) had its price target raised by The Goldman Sachs Group, Inc. from $430.00 to $490.00. The firm currently has a buy rating on the stock.
Stratasys (NASDAQ:SSYS) had its target price increased by Craig Hallum from $12.00 to $15.00. Craig Hallum currently has a buy rating on the stock.
Stratasys (NASDAQ:SSYS) had its price target raised by Needham & Company LLC from $10.00 to $12.00. Needham & Company LLC currently has a buy rating on the stock.
StepStone Group (NASDAQ:STEP) had its price target increased by Morgan Stanley from $60.00 to $65.00. They currently have an equal weight rating on the stock.
Smurfit Westrock (NYSE:SW) had its target price increased by Morgan Stanley from $60.00 to $64.00. The firm currently has an overweight rating on the stock.
Skyworks Solutions (NASDAQ:SWKS) had its price target reduced by B. Riley from $120.00 to $110.00. B. Riley currently has a buy rating on the stock.
Tarsus Pharmaceuticals (NASDAQ:TARS) had its price target raised by Oppenheimer Holdings Inc. from $63.00 to $65.00. Oppenheimer Holdings Inc. currently has an outperform rating on the stock.
Atlassian (NASDAQ:TEAM) had its price target boosted by Jefferies Financial Group Inc. from $280.00 to $300.00. The firm currently has a buy rating on the stock.
Tower Semiconductor (NASDAQ:TSEM) had its price target boosted by Susquehanna from $55.00 to $60.00. They currently have a positive rating on the stock.
Tesla (NASDAQ:TSLA) had its price target increased by Jefferies Financial Group Inc. from $195.00 to $300.00. They currently have a hold rating on the stock.
Tetra Tech (NASDAQ:TTEK) had its price target boosted by Robert W. Baird from $46.00 to $47.00. Robert W. Baird currently has a neutral rating on the stock.
TechTarget (NASDAQ:TTGT) had its target price trimmed by KeyCorp from $38.00 to $37.00. The firm currently has an overweight rating on the stock.
Travere Therapeutics (NASDAQ:TVTX) had its price target boosted by Piper Sandler from $12.00 to $22.00. Piper Sandler currently has a neutral rating on the stock.
UDR (NYSE:UDR) had its price target reduced by Scotiabank from $49.00 to $48.00. The firm currently has a sector perform rating on the stock.
UWM (NYSE:UWMC) had its price target reduced by The Goldman Sachs Group, Inc. from $8.50 to $7.50. The Goldman Sachs Group, Inc. currently has a neutral rating on the stock.
VICI Properties (NYSE:VICI) had its price target trimmed by Mizuho from $34.00 to $33.00. The firm currently has an outperform rating on the stock.
Viridian Therapeutics (NASDAQ:VRDN) had its target price boosted by HC Wainwright from $27.00 to $34.00. HC Wainwright currently has a buy rating on the stock.
W. P. Carey (NYSE:WPC) had its target price cut by UBS Group AG from $62.00 to $60.00. They currently have a neutral rating on the stock.
X4 Pharmaceuticals (NASDAQ:XFOR) had its target price trimmed by Stifel Nicolaus from $5.00 to $4.00. Stifel Nicolaus currently has a buy rating on the stock.
Zscaler (NASDAQ:ZS) had its price target increased by Stifel Nicolaus from $220.00 to $235.00. The firm currently has a buy rating on the stock.
Zevra Therapeutics (NASDAQ:ZVRA) had its target price trimmed by Canaccord Genuity Group Inc. from $25.00 to $23.00. The firm currently has a buy rating on the stock.
Receive News & Ratings for Acrivon Therapeutics Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acrivon Therapeutics Inc and related companies with MarketBeat.com's FREE daily email newsletter.
